Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Development and evaluation of a whole blood-based approach for flow cytometric quantification of CD154+ mould-reactive T cells.

Weis P, Helm J, Page L, Lauruschkat CD, Lazariotou M, Einsele H, Loeffler J, Ullmann AJ, Wurster S.

Med Mycol. 2019 May 16. pii: myz038. doi: 10.1093/mmy/myz038. [Epub ahead of print]

PMID:
31095327
2.

Comparative Analysis of Inflammatory Cytokine Release and Alveolar Epithelial Barrier Invasion in a Transwell® Bilayer Model of Mucormycosis.

Belic S, Page L, Lazariotou M, Waaga-Gasser AM, Dragan M, Springer J, Loeffler J, Morton CO, Einsele H, Ullmann AJ, Wurster S.

Front Microbiol. 2019 Jan 8;9:3204. doi: 10.3389/fmicb.2018.03204. eCollection 2018.

3.

New insights into chelator recycling by a chelating resin: From molecular mechanisms to applicability.

Dolev N, Katz Z, Ludmer Z, Ullmann A, Brauner N, Goikhman R.

Chemosphere. 2019 Jan;215:800-806. doi: 10.1016/j.chemosphere.2018.10.076. Epub 2018 Oct 15.

PMID:
30359949
4.

Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.

Brandt KS, Ullmann AJ, Molins CR, Horiuchi K, Biggerstaff BJ, Gilmore RD.

Diagn Microbiol Infect Dis. 2019 Mar;93(3):196-202. doi: 10.1016/j.diagmicrobio.2018.09.012. Epub 2018 Oct 3.

PMID:
30344068
5.

Evaluation of Aspergillus and Mucorales specific T-cells and peripheral blood mononuclear cell cytokine signatures as biomarkers of environmental mold exposure.

Page L, Weis P, Müller T, Dittrich M, Lazariotou M, Dragan M, Waaga-Gasser AM, Helm J, Dandekar T, Einsele H, Löffler J, Ullmann AJ, Wurster S.

Int J Med Microbiol. 2018 Dec;308(8):1018-1026. doi: 10.1016/j.ijmm.2018.09.002. Epub 2018 Sep 3.

PMID:
30201279
6.

Advancing micro-scale cooling by utilizing liquid-liquid phase separation.

Xing W, Ullmann A, Brauner N, Plawsky J, Peles Y.

Sci Rep. 2018 Aug 14;8(1):12093. doi: 10.1038/s41598-018-30584-6.

7.

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).

Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W, Heussel CP, Horger M, Kurzai O, Karthaus M, Löffler J, Maschmeyer G, Penack O, Rieger C, Rickerts V, Ritter J, Schmidt-Hieber M, Schuelper N, Schwartz S, Ullmann A, Vehreschild JJ, von Lilienfeld-Toal M, Weber T, Wolf HH.

Mycoses. 2018 Nov;61(11):796-813. doi: 10.1111/myc.12838. Epub 2018 Sep 3. Review.

PMID:
30098069
8.

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.

Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ.

Mycoses. 2018 Nov;61(11):868-876. doi: 10.1111/myc.12831. Epub 2018 Aug 13.

PMID:
30035825
9.

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Rieger CT, Liss B, Mellinghoff S, Buchheidt D, Cornely OA, Egerer G, Heinz WJ, Hentrich M, Maschmeyer G, Mayer K, Sandherr M, Silling G, Ullmann A, Vehreschild MJGT, von Lilienfeld-Toal M, Wolf HH, Lehners N; German Society of Hematology and Medical Oncology Infectious Diseases Working Group (AGIHO).

Ann Oncol. 2018 Jun 1;29(6):1354-1365. doi: 10.1093/annonc/mdy117.

10.

Position paper on current aspects of sponsoring in accredited CME.

Stolz D, Griebenow R, Tichelli A, Ullmann AJ, Costello RW, Michalis L, Guenova M, Sutter S, De Andrade F, Schaefer R.

J Eur CME. 2017 Apr 28;6(1):1312062. doi: 10.1080/21614083.2017.1312062. eCollection 2017.

11.

Susceptibility of A. fumigatus-specific T-cell assays to pre-analytic blood storage and PBMC cryopreservation greatly depends on readout platform and analytes.

Lauruschkat CD, Wurster S, Page L, Lazariotou M, Dragan M, Weis P, Ullmann AJ, Einsele H, Löffler J.

Mycoses. 2018 Aug;61(8):549-560. doi: 10.1111/myc.12780. Epub 2018 Jun 11.

PMID:
29611226
12.

Pulsatile dry cupping in chronic low back pain - a randomized three-armed controlled clinical trial.

Teut M, Ullmann A, Ortiz M, Rotter G, Binting S, Cree M, Lotz F, Roll S, Brinkhaus B.

BMC Complement Altern Med. 2018 Apr 2;18(1):115. doi: 10.1186/s12906-018-2187-8.

13.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

14.

Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents.

Decker C, Wurster S, Lazariotou M, Hellmann AM, Einsele H, Ullmann AJ, Löffler J.

Med Mycol. 2018 Jun 1;56(4):514-519. doi: 10.1093/mmy/myx069.

PMID:
29420763
15.

Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA.

Ann Hematol. 2018 Feb;97(2):197-207. doi: 10.1007/s00277-017-3196-2. Epub 2017 Dec 7. Review.

16.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

17.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3501. doi: 10.1093/jac/dkx382. No abstract available.

PMID:
29029280
18.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3406-3413. doi: 10.1093/jac/dkx263. Erratum in: J Antimicrob Chemother. 2017 Dec 1;72(12):3501.

PMID:
28961714
19.

Intra- and inter-individual variability of Aspergillus fumigatus reactive T-cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment.

Wurster S, Weis P, Page L, Helm J, Lazariotou M, Einsele H, Ullmann AJ.

Mycoses. 2017 Oct;60(10):668-675. doi: 10.1111/myc.12643. Epub 2017 Aug 8.

PMID:
28786508
20.

Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins.

Wurster S, Thielen V, Weis P, Walther P, Elias J, Waaga-Gasser AM, Dragan M, Dandekar T, Einsele H, Löffler J, Ullmann AJ.

Virulence. 2017 Nov 17;8(8):1708-1718. doi: 10.1080/21505594.2017.1342920. Epub 2017 Aug 8.

21.

e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study.

Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Schulz A, Schinzel H, Bickel C, Lauterbach M, Michal M, Hardt R, Binder H, Espinola-Klein C, Lackner KJ, Ten Cate H, Münzel T, Wild PS.

J Thromb Haemost. 2017 Jul;15(7):1375-1385. doi: 10.1111/jth.13727. Epub 2017 Jun 6.

22.

Lichen acclimation to changing environments: Photobiont switching vs. climate-specific uniqueness in Psora decipiens.

Williams L, Colesie C, Ullmann A, Westberg M, Wedin M, Büdel B.

Ecol Evol. 2017 Mar 16;7(8):2560-2574. doi: 10.1002/ece3.2809. eCollection 2017 Apr. Erratum in: Ecol Evol. 2017 Sep 06;7(17 ):7130.

23.

Screening and contact precautions - A survey on infection control measures for multidrug-resistant bacteria in German university hospitals.

Biehl LM, Bertz H, Bogner J, Dobermann UH, Kessel J, Krämer C, Lemmen S, von Lilienfeld-Toal M, Peter S, Pletz MW, Rohde H, Schmiedel S, Schubert S, Ullmann AJ, Fätkenheuer G, Vehreschild MJGT.

Antimicrob Resist Infect Control. 2017 Apr 13;6:37. doi: 10.1186/s13756-017-0191-2. eCollection 2017.

24.

Pollutant Ground Concentrations of Nonneutrally Buoyant Particles.

Mandel A, Stern E, Ullmann A, Brauner N.

Risk Anal. 2017 Dec;37(12):2435-2454. doi: 10.1111/risa.12800. Epub 2017 Mar 23.

PMID:
28334443
25.

The "Choosing Wisely" initiative in infectious diseases.

Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV, Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ, Fätkenheuer G, Jung N.

Infection. 2017 Jun;45(3):263-268. doi: 10.1007/s15010-017-0997-0. Epub 2017 Mar 13. Review.

PMID:
28290130
27.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
28.

Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.

Loeffler J, Hafner J, Mengoli C, Wirth C, Heussel CP, Löffler C, White PL, Ullmann AJ, Michel D, Wiegering V, Wölfl M, Schlegel PG, Einsele H, Springer J, Eyrich M.

J Clin Microbiol. 2016 Dec 28;55(1):101-109. doi: 10.1128/JCM.01682-16. Print 2017 Jan.

29.

Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Edmondson DG, Prabhakaran S, Norris SJ, Ullmann AJ, Piesman J, Dolan M, Probst C, Radzimski C, Stöcker W, Komorowski L.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00306-16. doi: 10.1128/CVI.00306-16. Print 2017 Jan.

30.

Quantification of A. fumigatus-specific CD154+ T-cells-preanalytic considerations.

Wurster S, Weis P, Page L, Lazariotou M, Einsele H, Ullmann AJ.

Med Mycol. 2017 Feb 1;55(2):223-227. doi: 10.1093/mmy/myw054. Epub 2016 Aug 2.

PMID:
27486216
31.

A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients.

Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJ.

Ann Oncol. 2016 Oct;27(10):1916-22. doi: 10.1093/annonc/mdw275. Epub 2016 Jul 25.

PMID:
27456299
32.

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation).

Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1. Epub 2016 Jun 24.

33.

Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.

Heinz WJ, Buchheidt D, Ullmann AJ.

Mycoses. 2016 Aug;59(8):480-93. doi: 10.1111/myc.12477. Epub 2016 Jun 21. Review.

PMID:
27324802
34.

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C; European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society.

Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.

35.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
36.

[Infectious diseases as a clinical specialty in Germany and Europe].

Kern WV, Fätkenheuer G, Tacconelli E, Ullmann A.

Z Evid Fortbild Qual Gesundhwes. 2015;109(7):493-9. doi: 10.1016/j.zefq.2015.09.015. Epub 2015 Oct 30. Review. German.

37.

Estimated burden of fungal infections in Germany.

Ruhnke M, Groll AH, Mayser P, Ullmann AJ, Mendling W, Hof H, Denning DW; University of Manchester in association with the LIFE program.

Mycoses. 2015 Oct;58 Suppl 5:22-8. doi: 10.1111/myc.12392.

PMID:
26449503
38.

Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.

Springer J, Lackner M, Nachbaur D, Girschikofsky M, Risslegger B, Mutschlechner W, Fritz J, Heinz WJ, Einsele H, Ullmann AJ, Löffler J, Lass-Flörl C.

Clin Microbiol Infect. 2016 Jan;22(1):80-86. doi: 10.1016/j.cmi.2015.09.009. Epub 2015 Sep 21.

39.

Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.

Weiner ZP, Crew RM, Brandt KS, Ullmann AJ, Schriefer ME, Molins CR, Gilmore RD.

Clin Vaccine Immunol. 2015 Nov;22(11):1176-86. doi: 10.1128/CVI.00399-15. Epub 2015 Sep 16.

40.

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.

Keller K, Prochaska JH, Coldewey M, Gobel S, Ullmann A, Jünger C, Lamparter H, Ariza L, Bickel C, Lauterbach M, Konstantinides S, Rostock T, Münzel T, Wild PS.

Thromb Res. 2015 Nov;136(5):899-906. doi: 10.1016/j.thromres.2015.08.024. Epub 2015 Sep 3.

PMID:
26376038
41.

Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.

Bacher P, Jochheim-Richter A, Mockel-Tenbrink N, Kniemeyer O, Wingenfeld E, Alex R, Ortigao A, Karpova D, Lehrnbecher T, Ullmann AJ, Hamprecht A, Cornely O, Brakhage AA, Assenmacher M, Bonig H, Scheffold A.

Cytotherapy. 2015 Oct;17(10):1396-405. doi: 10.1016/j.jcyt.2015.05.011. Epub 2015 Jul 15.

PMID:
26188965
42.

Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.

Frank B, Ariza L, Lamparter H, Grossmann V, Prochaska JH, Ullmann A, Kindler F, Weisser G, Walter U, Lackner KJ, Espinola-Klein C, Münzel T, Konstantinides SV, Wild PS; VTEval study group.

BMJ Open. 2015 Jul 1;5(7):e008157. doi: 10.1136/bmjopen-2015-008157.

43.

Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.

Ullmann AJ, Russell TM, Dolan MC, Williams M, Hojgaard A, Weiner ZP, Johnson BJ.

PLoS One. 2015 Jun 15;10(6):e0128868. doi: 10.1371/journal.pone.0128868. eCollection 2015.

44.

Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program.

Michal M, Prochaska JH, Keller K, Göbel S, Coldewey M, Ullmann A, Schulz A, Lamparter H, Münzel T, Reiner I, Beutel ME, Wild PS.

Int J Cardiol. 2015;187:614-9. doi: 10.1016/j.ijcard.2015.03.374. Epub 2015 Mar 27.

PMID:
25863736
45.

Riboflavin-UV--a crosslinking for fixation of biosynthetic corneal collagen implants.

Wand K, Neuhann R, Ullmann A, Plank K, Baumann M, Ritter R, Griffith M, Lohmann CP, Kobuch K.

Cornea. 2015 May;34(5):544-9. doi: 10.1097/ICO.0000000000000399.

PMID:
25768385
46.

Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.

Cornely OA, Böhme A, Schmitt-Hoffmann A, Ullmann AJ.

Antimicrob Agents Chemother. 2015 Apr;59(4):2078-85. doi: 10.1128/AAC.04569-14. Epub 2015 Jan 26.

47.

Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.

Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Jünger C, Al-Bayati Z, Baer C, Walter U, Bickel C, ten Cate H, Münzel T, Wild PS.

BMC Med. 2015 Jan 23;13:14. doi: 10.1186/s12916-015-0268-9.

48.

ESCMID guideline for the diagnosis and treatment of biofilm infections 2014.

Høiby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, Hall-Stoodley L, Holá V, Imbert C, Kirketerp-Møller K, Lebeaux D, Oliver A, Ullmann AJ, Williams C; ESCMID Study Group for Biofilms and Consulting External Expert Werner Zimmerli.

Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25. doi: 10.1016/j.cmi.2014.10.024. Epub 2015 Jan 14.

49.

Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.

Karbach S, Croxford AL, Oelze M, Schüler R, Minwegen D, Wegner J, Koukes L, Yogev N, Nikolaev A, Reißig S, Ullmann A, Knorr M, Waldner M, Neurath MF, Li H, Wu Z, Brochhausen C, Scheller J, Rose-John S, Piotrowski C, Bechmann I, Radsak M, Wild P, Daiber A, von Stebut E, Wenzel P, Waisman A, Münzel T.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2658-68. doi: 10.1161/ATVBAHA.114.304108. Epub 2014 Oct 23.

PMID:
25341795
50.

[Patient with COPD after allogeneic hematopoietic stem cell transplantation with cough and subfebrile temperature].

Rau M, Heinz W, Ullmann AJ.

Dtsch Med Wochenschr. 2014 Oct;139(44):2239-41. doi: 10.1055/s-0034-1387312. Epub 2014 Oct 21. German.

PMID:
25334076

Supplemental Content

Loading ...
Support Center